KYMERA THERAPEUTICS INC (KYMR) Stock Analyst Ratings
NASDAQ:KYMR - Nasdaq - US5015751044 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to KYMR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 60.13. This target is 63.34% above the current price.
KYMR was analyzed by 26 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about KYMR.
In the previous month the buy percentage consensus was at a similar level.
KYMR was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-21 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-12-27 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-12-10 | BTIG | Initiate | Buy |
| 2024-12-06 | BMO Capital | Initiate | Market Perform |
| 2024-12-02 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-11-18 | Stephens & Co. | Initiate | Overweight |
| 2024-11-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-04 | UBS | Maintains | Buy -> Buy |
| 2024-11-01 | Guggenheim | Maintains | Buy -> Buy |
| 2024-11-01 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-09-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-26 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2024-08-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-12 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-07-10 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-07-09 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2024-06-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-22 | Oppenheimer | Initiate | Outperform |
| 2024-03-01 | Truist Securities | Maintains | Buy -> Buy |
| 2024-02-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-23 | Stifel | Maintains | Buy -> Buy |
| 2024-02-23 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-15 | Wolfe Research | Initiate | Peer Perform |
| 2024-01-03 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-12-19 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2023-11-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-03 | Piper Sandler | Maintains | Overweight -> Overweight |